Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02671448 · ClinicalTrials.gov registry record · NA
Pilot Trial of Homebound Stem Cell Transplantation
A NA study of Plasma Cell Dyscrasia, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT02671448: Recruiting NA study of Plasma Cell Dyscrasia, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02671448 is a NA study of Plasma Cell Dyscrasia that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02671448, a NA study of Plasma Cell Dyscrasia, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).
Primary Outcome
the homebound procedure will be considered promising if no more than 10 patients are readmitted to the hospital within 21 days.
Conditions Studied
Interventions
- BEHAVIORAL Home monitoring teleconsult visits
- BEHAVIORAL Patient Reported Outcomes (PRO)
- BEHAVIORAL Caregiver Reported Outcomes instruments
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT02671448 shows while recruiting
NCT02671448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Plasma Cell Dyscrasia appearing as the primary indexed condition, and to 3 interventions - of which Home monitoring teleconsult visits is the first listed.
NCT02671448 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02671448 about?
NCT02671448 is a clinical study titled "Pilot Trial of Homebound Stem Cell Transplantation". In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient...
What is the current status of trial NCT02671448?
This trial is currently recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2016-01. Estimated completion is 2027-01.
What conditions does trial NCT02671448 study?
This clinical trial studies the following conditions: Plasma Cell Dyscrasia.
What interventions are being tested in trial NCT02671448?
The interventions under investigation include: Home monitoring teleconsult visits (BEHAVIORAL), Patient Reported Outcomes (PRO) (BEHAVIORAL), Caregiver Reported Outcomes instruments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02671448?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02671448 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasma Cell Dyscrasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02671448's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
- NCT05847192 · 91 participants
Tau Networks in Psychotic Alzheimer's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia